Generex Biotechnology News

News on Generex Biotechnology (Ticker: GNBT) continually updated from thousands of sources around the net.

Monday May 21 | BioSpace

Generex Biotechnology Corporation Augments Antigen Express, Inc. Scientific Advisory Board

The following distinguished scientists, scholars, and physicians join Dr. in 1996 and completed a residency in internal medicine at Johns Hopkins Hospital.

Comment?

Thu May 17, 2012

Freshnews

Generex Announces New Members of Antigen Express Scientific Advisory...

WORCESTER, Mass. and TORONTO, May 17, 2012 /PRNewswire/ -- Generex Biotechnology Corporation is pleased to announce today that new members have joined the Scientific Advisory Board of its wholly-owned subsidiary, Antigen Express, Inc.

Comment?

Tue May 15, 2012

Rehab Management

Generex Enhances Antigen Express Scientific Advisory Board for the...

Miller's career combines both laboratory and clinical research in breast cancer.

Comment?

Wed May 09, 2012

Rehab Management

Generex Announces Establishment of a Scientific Advisory Board for Antigen Express

The function of the SAB is to provide advice and assistance to Antigen Express in respect of the clinical and regulatory programs for the Company's immuno-therapeutic cancer vaccines.

Comment?

Tue May 08, 2012

Freshnews

Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012

WORCESTER, Mass. and TORONTO, May 8, 2012 /PRNewswire/ -- Generex Biotechnology Corporation announced today that abstracts featuring the AE37 breast cancer vaccine clinical program of Generex wholly-owned subsidiary Antigen Express, Inc.

Comment?